US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEUROGENE INC

18.48

-0.3600-1.91%

Post-market: 18.480.00000.00%16:10 EDT

Volume:94.97K

Turnover:1.75M

Market Cap:263.74M

PE:-4.29

High:19.01

Open:18.92

Low:18.00

Close:18.84

52wk High:74.49

52wk Low:6.88

Shares:14.27M

Float Shares:4.80M

Volume Ratio:0.97

T/O Rate:1.98%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.3039

EPS(LYR):-4.2775

ROE:-39.41%

ROA:-25.07%

PB:0.97

PE(LYR):-4.32

Loading ...

Overview Company News Filings

H.C. Wainwright Remains a Buy on Neurogene (NGNE)

BRIEF-Neurogene Announces Upcoming Oral Presentation On Monitoring And Treatment To Reverse Rare Complication Of High Dose Gene Therapy

Neurogene Inc. to Present on Monitoring and Treatment of HLH at ASGCT Annual Meeting

Neurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare Complication of High Dose Gene Therapy at the ASGCT Annual Meeting

BRIEF-Neurogene Amends Agreement With Baker Bros To Increase Nomination Threshold

Neurogene Is Maintained at Outperform by BMO Capital

Neurogene announces peer-reviewed publication of EXACT transgene technology

Biotech stocks slide as Marks resignation seen being negative for sector

Neurogene files $300M mixed securities shelf

Neurogene price target lowered to $38 from $46 at Baird

Neurogene Is Maintained at Buy by HC Wainwright & Co.

Neurogene Inc reports results for the quarter ended December 31 - Earnings Summary

Neurogene Q4 Net Profit $(19.5)M Down From $2.4M YoY

BRIEF-Neurogene Inc Files For Mixed Shelf Offering Of Up To $300 Million - SEC Filing

BRIEF-Neurogene FY Net Income USD -75.144 Million

Press Release: Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates

North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs

Neurogene to Participate in Upcoming Conferences

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NGNE/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NGNE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGNE\",,,,,undefined,":{"symbol":"NGNE","market":"US","secType":"STK","nameCN":"NEUROGENE INC","latestPrice":18.48,"timestamp":1756497600000,"preClose":18.84,"halted":0,"volume":94969,"hourTrading":{"tag":"盘后","latestPrice":18.48,"preClose":18.48,"latestTime":"16:10 EDT","volume":1581,"amount":29216.88,"timestamp":1756498204688},"delay":0,"floatShares":4799599,"shares":14271900,"eps":-4.303895,"marketStatus":"Market Closed","change":-0.36,"latestTime":"08-29 16:00:00 EDT","open":18.92,"high":19.005,"low":18,"amount":1747724.9832,"amplitude":0.053344,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.303895,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":7,"adr":0,"listingDate":1394168400000,"exchange":"NASDAQ","adjPreClose":18.84,"preHourTrading":{"tag":"盘前","latestPrice":20,"preClose":18.84,"latestTime":"08:00 EDT","volume":10,"amount":200,"timestamp":1756468801760},"postHourTrading":{"tag":"盘后","latestPrice":18.48,"preClose":18.48,"latestTime":"16:10 EDT","volume":1581,"amount":29216.88,"timestamp":1756498204688},"volumeRatio":0.9688934690408362,"impliedVol":1.0717,"impliedVolPercentile":0.504},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGNE\",,,,,undefined,":{"symbol":"NGNE","floatShares":4799599,"roa":"-25.07%","roe":"-39.41%","lyrEps":-4.277545,"volumeRatio":0.9688934690408362,"shares":14271900,"dividePrice":0,"high":19.005,"amplitude":0.053344,"preClose":18.84,"low":18,"week52Low":6.875,"pbRate":"0.97","week52High":74.49,"institutionHeld":0,"latestPrice":18.48,"eps":-4.303895,"divideRate":0,"volume":94969,"delay":0,"ttmEps":-4.303895,"open":18.92,"prevYearClose":22.86,"prevWeekClose":19.99,"prevMonthClose":21.77,"prevQuarterClose":14.95,"fiveDayClose":19.99,"twentyDayClose":21.78,"sixtyDayClose":21.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NGNE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-11","symbol":"NGNE","fiscalQuarterEnding":"2025/06","expectedEps":-1.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-1.05},{"market":"US","date":"2025-05-09","symbol":"NGNE","fiscalQuarterEnding":"2025/03","expectedEps":-1.05,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-1.08},{"market":"US","date":"2025-03-24","symbol":"NGNE","fiscalQuarterEnding":"2024/12","expectedEps":-1.04,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"post","actualEps":-0.99},{"market":"US","date":"2024-11-18","symbol":"NGNE","fiscalQuarterEnding":"2024/09","expectedEps":-1.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731906000000,"reportTimeType":"post","actualEps":-1.19},{"market":"US","date":"2024-08-09","symbol":"NGNE","fiscalQuarterEnding":"2024/06","expectedEps":-1.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"pre","actualEps":-1.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NGNE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NGNE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1750219200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NGNE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NGNE","date":"2025-08-29","current":-3.186043,"percent":0.875,"low":-19.523035,"twenty":-11.623292,"median":-7.086806,"eighty":-3.597702,"high":-1.458307,"avg":-7.668792,"sd":4.131838,"marketCap":268882897},"quantilePoints":[{"date":"2023-12-29","current":-4.323556,"twenty":-4.185645,"median":-3.978778,"eighty":-3.916869,"marketCap":220311097},{"date":"2024-01-05","current":-5.423319,"twenty":-5.000527,"median":-4.624292,"eighty":-3.978778,"marketCap":276350648},{"date":"2024-01-12","current":-8.005373,"twenty":-7.157271,"median":-5.423319,"eighty":-4.323556,"marketCap":407921769},{"date":"2024-01-19","current":-7.59768,"twenty":-7.599292,"median":-7.086806,"eighty":-4.804734,"marketCap":387147382},{"date":"2024-01-26","current":-8.053188,"twenty":-7.611677,"median":-7.561189,"eighty":-4.985427,"marketCap":410358272},{"date":"2024-02-02","current":-7.741127,"twenty":-7.937424,"median":-7.577547,"eighty":-5.338761,"marketCap":394456888},{"date":"2024-02-09","current":-7.497015,"twenty":-7.980207,"median":-7.59013,"eighty":-6.388695,"marketCap":382017903},{"date":"2024-02-16","current":-7.549864,"twenty":-7.937424,"median":-7.577547,"eighty":-6.995453,"marketCap":384710880},{"date":"2024-02-23","current":-7.622846,"twenty":-7.894138,"median":-7.57503,"eighty":-7.129085,"marketCap":388429751},{"date":"2024-03-01","current":-7.819143,"twenty":-7.894138,"median":-7.588872,"eighty":-7.262969,"marketCap":398432234},{"date":"2024-03-08","current":-9.734292,"twenty":-8.024499,"median":-7.59768,"eighty":-7.381754,"marketCap":496020561},{"date":"2024-03-15","current":-8.697444,"twenty":-8.083388,"median":-7.629138,"eighty":-7.463796,"marketCap":443186933},{"date":"2024-03-22","current":-17.419498,"twenty":-9.10262,"median":-7.660596,"eighty":-7.498525,"marketCap":632623921},{"date":"2024-03-28","current":-17.433655,"twenty":-9.373408,"median":-7.741127,"eighty":-7.499532,"marketCap":633138041},{"date":"2024-04-05","current":-15.090764,"twenty":-9.721205,"median":-7.845567,"eighty":-7.510605,"marketCap":548051280},{"date":"2024-04-12","current":-13.565408,"twenty":-14.180505,"median":-7.97769,"eighty":-7.536275,"marketCap":492654915},{"date":"2024-04-19","current":-11.176509,"twenty":-13.912948,"median":-8.029281,"eighty":-7.549864,"marketCap":405897266},{"date":"2024-04-26","current":-10.571321,"twenty":-13.650346,"median":-8.053188,"eighty":-7.549864,"marketCap":383918661},{"date":"2024-05-03","current":-12.537284,"twenty":-13.442874,"median":-8.146303,"eighty":-7.558924,"marketCap":455316556},{"date":"2024-05-10","current":-11.764996,"twenty":-13.2542,"median":-9.074937,"eighty":-7.57352,"marketCap":427269365},{"date":"2024-05-17","current":-10.587696,"twenty":-13.13876,"median":-9.272492,"eighty":-7.576037,"marketCap":433830864},{"date":"2024-05-24","current":-9.887502,"twenty":-12.800854,"median":-9.44488,"eighty":-7.581574,"marketCap":405140389},{"date":"2024-05-31","current":-10.685033,"twenty":-12.52136,"median":-9.620612,"eighty":-7.588117,"marketCap":437819226},{"date":"2024-06-07","current":-11.771752,"twenty":-12.409114,"median":-9.810897,"eighty":-7.59013,"marketCap":482347539},{"date":"2024-06-14","current":-13.301826,"twenty":-12.457666,"median":-9.93146,"eighty":-7.59013,"marketCap":545042335},{"date":"2024-06-21","current":-9.842528,"twenty":-12.564112,"median":-9.93146,"eighty":-7.59617,"marketCap":403297579},{"date":"2024-06-28","current":-11.030474,"twenty":-12.52136,"median":-10.019377,"eighty":-7.599292,"marketCap":451973662},{"date":"2024-07-05","current":-11.397945,"twenty":-12.537284,"median":-10.188931,"eighty":-7.605739,"marketCap":467030798},{"date":"2024-07-12","current":-13.232134,"twenty":-12.537284,"median":-10.458961,"eighty":-7.622846,"marketCap":542186671},{"date":"2024-07-15","current":-13.48873,"twenty":-12.644595,"median":-10.463671,"eighty":-7.625363,"marketCap":552700705},{"date":"2024-08-02","current":-12.832984,"twenty":-12.76836,"median":-10.468381,"eighty":-7.627879,"marketCap":525831507},{"date":"2024-08-09","current":-11.578513,"twenty":-12.617767,"median":-10.579508,"eighty":-7.644992,"marketCap":474429562},{"date":"2024-08-16","current":-9.721942,"twenty":-12.533918,"median":-10.468381,"eighty":-7.659841,"marketCap":462832495},{"date":"2024-08-23","current":-9.22793,"twenty":-12.500388,"median":-10.20777,"eighty":-7.686769,"marketCap":439314055},{"date":"2024-08-30","current":-9.934831,"twenty":-12.3607,"median":-10.082175,"eighty":-7.732068,"marketCap":472967513},{"date":"2024-09-06","current":-9.383503,"twenty":-12.215183,"median":-10.030358,"eighty":-7.751697,"marketCap":446720414},{"date":"2024-09-13","current":-11.015654,"twenty":-12.198503,"median":-10.056266,"eighty":-7.799009,"marketCap":524422220},{"date":"2024-09-20","current":-11.343175,"twenty":-12.111032,"median":-10.20463,"eighty":-7.829713,"marketCap":540014556},{"date":"2024-09-27","current":-10.69359,"twenty":-12.018852,"median":-10.282823,"eighty":-7.883065,"marketCap":509089757},{"date":"2024-10-04","current":-12.12104,"twenty":-12.018852,"median":-10.468381,"eighty":-7.937424,"marketCap":577046353},{"date":"2024-10-11","current":-13.141817,"twenty":-12.215183,"median":-10.579508,"eighty":-7.980207,"marketCap":625642465},{"date":"2024-10-18","current":-14.443716,"twenty":-12.644595,"median":-10.678753,"eighty":-7.993293,"marketCap":687621999},{"date":"2024-10-25","current":-13.155463,"twenty":-12.975228,"median":-10.69616,"eighty":-8.014936,"marketCap":626292146},{"date":"2024-10-31","current":-11.938174,"twenty":-12.976568,"median":-10.764003,"eighty":-8.053188,"marketCap":568340632},{"date":"2024-11-08","current":-18.968977,"twenty":-13.201862,"median":-10.833215,"eighty":-8.053188,"marketCap":903056103},{"date":"2024-11-15","current":-10.699049,"twenty":-13.232134,"median":-10.867118,"eighty":-8.053188,"marketCap":509349629},{"date":"2024-11-22","current":-3.804354,"twenty":-13.201862,"median":-10.811892,"eighty":-8.005373,"marketCap":202570426},{"date":"2024-11-29","current":-7.081932,"twenty":-13.164743,"median":-10.73726,"eighty":-7.916284,"marketCap":377091628},{"date":"2024-12-06","current":-6.123936,"twenty":-13.144546,"median":-10.69616,"eighty":-7.738107,"marketCap":326081199},{"date":"2024-12-13","current":-6.220014,"twenty":-13.009618,"median":-10.678753,"eighty":-7.632912,"marketCap":331197071},{"date":"2024-12-20","current":-6.147607,"twenty":-12.971208,"median":-10.579508,"eighty":-7.59013,"marketCap":327341631},{"date":"2024-12-27","current":-6.711544,"twenty":-12.908645,"median":-10.50763,"eighty":-7.57654,"marketCap":357369573},{"date":"2025-01-03","current":-6.374574,"twenty":-12.853892,"median":-10.405691,"eighty":-7.549864,"marketCap":339426951},{"date":"2025-01-10","current":-5.995231,"twenty":-12.800672,"median":-10.212067,"eighty":-7.505069,"marketCap":319228040},{"date":"2025-01-17","current":-4.918377,"twenty":-12.651961,"median":-10.173232,"eighty":-7.427764,"marketCap":261888801},{"date":"2025-01-24","current":-4.346472,"twenty":-12.574112,"median":-10.030358,"eighty":-7.086806,"marketCap":231436615},{"date":"2025-01-31","current":-4.332524,"twenty":-12.537284,"median":-9.920586,"eighty":-6.842433,"marketCap":230693879},{"date":"2025-02-07","current":-6.50018,"twenty":-12.535901,"median":-9.842528,"eighty":-6.605719,"marketCap":346115092},{"date":"2025-02-14","current":-5.236411,"twenty":-12.52887,"median":-9.777894,"eighty":-6.491539,"marketCap":278823188},{"date":"2025-02-21","current":-4.829104,"twenty":-12.471907,"median":-9.750601,"eighty":-6.430271,"marketCap":257135289},{"date":"2025-02-28","current":-4.770518,"twenty":-12.349943,"median":-9.721942,"eighty":-6.303838,"marketCap":254015797},{"date":"2025-03-07","current":-4.672876,"twenty":-12.236804,"median":-9.661093,"eighty":-6.2189,"marketCap":248816643},{"date":"2025-03-14","current":-4.686825,"twenty":-12.214976,"median":-9.588204,"eighty":-6.130619,"marketCap":249559380},{"date":"2025-03-21","current":-4.24883,"twenty":-12.149292,"median":-9.555425,"eighty":-6.004158,"marketCap":226237461},{"date":"2025-03-28","current":-3.045755,"twenty":-12.12341,"median":-9.468113,"eighty":-5.45457,"marketCap":228870246},{"date":"2025-04-04","current":-1.92123,"twenty":-12.043093,"median":-9.418302,"eighty":-5.225252,"marketCap":144368903},{"date":"2025-04-11","current":-1.782154,"twenty":-12.004592,"median":-9.374415,"eighty":-5.034123,"marketCap":133918207},{"date":"2025-04-17","current":-2.044108,"twenty":-11.997937,"median":-9.328916,"eighty":-4.961897,"marketCap":153602450},{"date":"2025-04-25","current":-2.917172,"twenty":-11.976697,"median":-9.167755,"eighty":-4.922368,"marketCap":219207954},{"date":"2025-05-02","current":-2.922866,"twenty":-11.956745,"median":-9.074937,"eighty":-4.83359,"marketCap":219635816},{"date":"2025-05-09","current":-2.846947,"twenty":-11.943832,"median":-8.430682,"eighty":-4.764939,"marketCap":213930990},{"date":"2025-05-16","current":-3.416053,"twenty":-11.921952,"median":-8.053188,"eighty":-4.703006,"marketCap":276256218},{"date":"2025-05-23","current":-3.181497,"twenty":-11.907794,"median":-8.053188,"eighty":-4.667296,"marketCap":257287670},{"date":"2025-05-30","current":-3.304948,"twenty":-11.891321,"median":-7.997823,"eighty":-4.63103,"marketCap":267271116},{"date":"2025-06-06","current":-4.042124,"twenty":-11.854896,"median":-7.927357,"eighty":-4.432955,"marketCap":326886552},{"date":"2025-06-13","current":-3.597702,"twenty":-11.83216,"median":-7.80656,"eighty":-4.329176,"marketCap":290946146},{"date":"2025-06-20","current":-3.22735,"twenty":-11.824338,"median":-7.733577,"eighty":-4.305184,"marketCap":260995807},{"date":"2025-06-27","current":-2.922251,"twenty":-11.790759,"median":-7.659337,"eighty":-4.202034,"marketCap":236322433},{"date":"2025-07-03","current":-3.543031,"twenty":-11.778088,"median":-7.622846,"eighty":-3.964273,"marketCap":286524905},{"date":"2025-07-11","current":-3.87282,"twenty":-11.778088,"median":-7.593905,"eighty":-3.821676,"marketCap":313194969},{"date":"2025-07-18","current":-3.985689,"twenty":-11.771752,"median":-7.587614,"eighty":-3.805804,"marketCap":322322691},{"date":"2025-07-25","current":-4.022724,"twenty":-11.764996,"median":-7.573772,"eighty":-3.819913,"marketCap":325317725},{"date":"2025-08-01","current":-3.839312,"twenty":-11.670697,"median":-7.549864,"eighty":-3.819913,"marketCap":310485176},{"date":"2025-08-08","current":-3.784641,"twenty":-11.657709,"median":-7.513374,"eighty":-3.804354,"marketCap":306063936},{"date":"2025-08-15","current":-3.416033,"twenty":-11.655175,"median":-7.497015,"eighty":-3.77935,"marketCap":288292703},{"date":"2025-08-22","current":-3.339933,"twenty":-11.654541,"median":-7.373701,"eighty":-3.740907,"marketCap":281870341},{"date":"2025-08-29","current":-3.186043,"twenty":-11.623292,"median":-7.086806,"eighty":-3.597702,"marketCap":268882897}],"updateTime":1756583394684},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NGNE\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533852099","title":"H.C. Wainwright Remains a Buy on Neurogene (NGNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533852099","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533852099?lang=en_us&edition=fundamental","pubTime":"2025-05-06 15:45","pubTimestamp":1746517553,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Mitchell Kapoor from H.C. Wainwright maintained a Buy rating on Neurogene (NGNE – Research Report), with a price ta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-neurogene-ngne?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-neurogene-ngne?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2531269741","title":"BRIEF-Neurogene Announces Upcoming Oral Presentation On Monitoring And Treatment To Reverse Rare Complication Of High Dose Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2531269741","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531269741?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:01","pubTimestamp":1745874081,"startTime":"0","endTime":"0","summary":"BRIEF-Neurogene Announces Upcoming Oral Presentation On Monitoring And Treatment To Reverse Rare Complication Of High Dose Gene Therapy April 28 (Reuters) - Neurogene Inc NGNE.O:NEUROGENE ANNOUNCES UP","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nTUA3TMHTV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2531647292","title":"Neurogene Inc. to Present on Monitoring and Treatment of HLH at ASGCT Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2531647292","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531647292?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:00","pubTimestamp":1745874033,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurogene Inc. published the original content used to generate this news brief via Business Wire  on April 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nNDL9TPpbM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2531163264","title":"Neurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare Complication of High Dose Gene Therapy at the ASGCT Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2531163264","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531163264?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:00","pubTimestamp":1745874000,"startTime":"0","endTime":"0","summary":"Presentation will highlight examples of successful surveillance and treatment of HLH in the context of gene therapy. \"Given the limited published research on HLH related to gene therapy, we believe it is important to provide information to the AAV gene therapy community on effective approaches to monitor, treat and reverse cases of HLH,\" said Rachel McMinn, Ph.D., Founder and Chief Executive Officer of Neurogene. \"In our ongoing clinical trial of NGN-401 gene therapy for Rett syndrome, we have implemented early monitoring and a treatment plan into our protocol, and we encourage others to do the same.\". The 1E15 vg dose level Neurogene is moving forward in its Phase 1/2 trial of NGN-401 gene therapy for Rett syndrome translates into the E13 vg/kg range, and the Company is not aware of any case of HLH ever being reported at this dose level.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurogene-announces-upcoming-oral-presentation-210000118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2527409921","title":"BRIEF-Neurogene Amends Agreement With Baker Bros To Increase Nomination Threshold","url":"https://stock-news.laohu8.com/highlight/detail?id=2527409921","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527409921?lang=en_us&edition=fundamental","pubTime":"2025-04-15 05:35","pubTimestamp":1744666531,"startTime":"0","endTime":"0","summary":"BRIEF-Neurogene Amends Agreement With Baker Bros To Increase Nomination Threshold April 14  - Neurogene Inc NGNE.O:NEUROGENE INC - AMENDS AGREEMENT WITH BAKER BROS TO INCREASE NOMINATION THRESHOLD - SEC FILINGNEUROGENE : INCREASES NOMINATION THRESHOLD AT WHICH BBA HAS CERTAIN RIGHTS TO NOMINATE ONE PERSON AS DIRECTOR TO 14.9% OF VOTING STOCKFurther company coverage: NGNE.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QS26F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2527152998","title":"Neurogene Is Maintained at Outperform by BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2527152998","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527152998?lang=en_us&edition=fundamental","pubTime":"2025-04-14 20:08","pubTimestamp":1744632480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NGNE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2025 08:08 ET (12:08 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMO","NGNE"],"gpt_icon":0},{"id":"2524446541","title":"Neurogene announces peer-reviewed publication of EXACT transgene technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2524446541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524446541?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:06","pubTimestamp":1743624400,"startTime":"0","endTime":"0","summary":"The company states: “Neurogene (NGNE) announced a peer-reviewed publication on its EXACT transgene regulation technology. The preclinical studies d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurogene-announces-peer-reviewed-publication-of-exact-transgene-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurogene-announces-peer-reviewed-publication-of-exact-transgene-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2524491531","title":"Biotech stocks slide as Marks resignation seen being negative for sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2524491531","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524491531?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:50","pubTimestamp":1743522637,"startTime":"0","endTime":"0","summary":"Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and Research, Peter Marks. RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a “significant negative” for the biopharma and biotech sectors.Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks.“NOT GOOD” FOR BIOTECH SECTOR: RBC Capital believes the resignation of the head of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, is “not good for the biotech industry even beyond vaccines.” Marks had been a key advocate for more flexible, efficient approval processes for drugs, particularly those for orphan diseases such as gene therapies, the firm tells investors in a research note.PRICE ACTION: In mornin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0058720904.USD","LU2362540622.SGD","BK4551","LU0823416689.USD","RCKT","LU1066053197.SGD","IE0002141913.USD","TSHA","LU2462157665.USD","NGNE","REGN","LU0417517546.SGD","MGX","MGTX","CRSP","LU0320765992.SGD","IE00BFTCPJ56.SGD","LEGN","DYN","RCKTW","BK4578","GLPG","LU1069344957.HKD","LU1035775433.USD","PTCT","IE0009355771.USD","LU1571399168.USD","NTLA","SRPT","PRME","BK4007","PCRX","KPTI","BK4532","IE00BZ9MQY76.HKD","MRNA","RGNX","IE00B3T34201.USD","GILD","LU1066051498.USD","IE00B4R5TH58.HKD","BEAM","VRTX","VERV","BK4568","LU1430594728.SGD","FDMT","LU2468319806.SGD","RNA","DTIL","BK4139","LU2023250504.SGD"],"gpt_icon":1},{"id":"2522750884","title":"Neurogene files $300M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2522750884","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522750884?lang=en_us&edition=fundamental","pubTime":"2025-03-26 03:18","pubTimestamp":1742930338,"startTime":"0","endTime":"0","summary":"16:35 EDT Neurogene (NGNE) files $300M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurogene-files-300m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurogene-files-300m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522881034","title":"Neurogene price target lowered to $38 from $46 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2522881034","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522881034?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:59","pubTimestamp":1742929142,"startTime":"0","endTime":"0","summary":"Baird analyst Joel Beatty lowered the firm’s price target on Neurogene (NGNE) to $38 from $46 and keeps an Outperform rating on the shares. The fir...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurogene-price-target-lowered-to-38-from-46-at-baird?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurogene-price-target-lowered-to-38-from-46-at-baird?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522291260","title":"Neurogene Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2522291260","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522291260?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:32","pubTimestamp":1742902320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NGNE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2025 07:32 ET (11:32 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE"],"gpt_icon":0},{"id":"2522085674","title":"Neurogene Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522085674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522085674?lang=en_us&edition=fundamental","pubTime":"2025-03-25 05:33","pubTimestamp":1742851983,"startTime":"0","endTime":"0","summary":"Neurogene Inc reports results for the quarter ended December 31 - Earnings SummaryNeurogene Inc NGNE.OQ reported a quarterly adjusted loss of 99 cents per share for the quarter ended December 31, high","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nL5N3Q7201:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE"],"gpt_icon":0},{"id":"2522088469","title":"Neurogene Q4 Net Profit $(19.5)M Down From $2.4M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2522088469","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522088469?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:53","pubTimestamp":1742849638,"startTime":"0","endTime":"0","summary":"Neurogene Q4 Net Profit $(19.5)M Down From $2.4M YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44465862/neurogene-q4-net-profit-19-5-m-down-from-2-4m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522263700","title":"BRIEF-Neurogene Inc Files For Mixed Shelf Offering Of Up To $300 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522263700","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522263700?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:38","pubTimestamp":1742848737,"startTime":"0","endTime":"0","summary":"BRIEF-Neurogene Inc Files For Mixed Shelf Offering Of Up To $300 Million - SEC FilingMarch 24  - Neurogene Inc NGNE.O:NEUROGENE INC: FILES FOR MIXED SHELF OFFERING OF UP TO $300 MILLION - SEC FILINGSource text: [ID:n0001628280-25-014521]Further company coverage: NGNE.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q71D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2522707976","title":"BRIEF-Neurogene FY Net Income USD -75.144 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707976","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707976?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847045,"startTime":"0","endTime":"0","summary":"BRIEF-Neurogene FY Net Income USD -75.144 Million\n\n\nMar 24 (Reuters) - Neurogene FY operating income USD -82.605 million.\n\nFY operating expenses USD 83.53 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nPLX3DFE3C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2522770718","title":"Press Release: Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522770718","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522770718?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847000,"startTime":"0","endTime":"0","summary":"Remains on track to provide regulatory update on registrational trial plans with NGN-401 for Rett syndrome in the first half of 2025. Continues to expect to share additional interim clinical data from NGN-401 Phase 1/2 trial in the second half of 2025. Received PRIME designation for NGN-401 from the European Medicines Agency. Neurogene Inc. , a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced fourth quarter and full year 2024 financial results and highlighted recent corporate updates.Fourth Quarter 2024 and Recent Highlights, and Anticipated Milestones. -- Protocol amended and submitted to U.S. Food and Drug Administration . participants expected to be dosed during the first half of the year","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0971096721.USD","IE00BHPRN162.USD","NGNE","TM","BK4099","BK4555","IE00B1BXHZ80.USD","BK4588","IE00BKVL7J92.USD","LU0170899867.USD","LU0267386448.USD","BK4139","03160","IE00BZ1G4Q59.USD","LU0882574139.USD","BK4006","LU0149725797.USD","BK4585","CMC","BK4604","LU1363072403.SGD"],"gpt_icon":0},{"id":"2521037934","title":"North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2521037934","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521037934?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:02","pubTimestamp":1742551320,"startTime":"0","endTime":"0","summary":"The euphoria from the Federal Reserve's policy meeting didn't last long.Stock futures were lower Friday as attention shifted from the Fed to the prospect of further tariffs.Trump said in a social media post that the planned imposition of reciprocal tariffs on April 2 would be \"Liberation Day\" in the U.S.\"We maintain our view that the FOMC outcome was effectively a one-day move, with minimal legacy in terms of immediate direction. That said, we also view the FOMC outcome as a whole as nodding towards dovishness, but with numerous caveats,\" ING said.Quantum-computing stocks  are likely to be in focus after suffering steep falls on Thursday as investors appeared unimpressed by their contributions to Nvidia's Quantum Day at its GTC developers' event.The market also faces a test as an estimated $4.5 trillion in options contracts expire, which could increase volatility.FedEx fell 5.1% off hours after it cut its outlook for the year.Lennar management warned investors of a weak housing market.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","CCL","3NVD.UK","ADVM","BPTH","US7Y.BOND","NVDD","DM","CKPT","PRPH","NVDA","AFG","US6M.BOND","NVDX","SNVD.UK","JVA","MPU","NVDS","2NVD.UK","NVDU","ATXI","IMNM","ET","FBRX","ZBIO","NVDS.UK","NVD2.UK","US12M.BOND","US2Y.BOND","XOMA","NVDL","BOLD","US5Y.BOND","US30Y.BOND","US10Y.BOND","NVD3.UK","GORV","IMRX","PURE","FBLG","SMXT","DXYN","US3Y.BOND","SGMA","NVDY","NVIW.SI","OLMA","IRD","USAU"],"gpt_icon":1},{"id":"2513725817","title":"Neurogene to Participate in Upcoming Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2513725817","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513725817?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:30","pubTimestamp":1740400200,"startTime":"0","endTime":"0","summary":"NEW YORK, February 24, 2025----Neurogene Inc. , a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the following conferences:. TD Cowen 45th Annual Health Care ConferenceFormat: Management will participate in a fireside chat and investor meetingsDate: Monday, March 3 at 9:50 a.m. ET. Leerink Global Healthcare ConferenceFormat: Management will participate in a fireside chat and investor meetingsDate: Monday, March 10 at 1:00 p.m. ET. Stifel Virtual CNS ForumFormat: Management will participate in a fireside chatDate: Wednesday, March 19 at 9:30 a.m. ET. Live webcasts of the fireside chats will be accessible from the Investor Relations section of Neurogene’s website under events, where a replay of the events will also be available for a limited time.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurogene-participate-upcoming-conferences-123000601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NGNE","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":58,"code":"91000000","status":"200"}]}}